Human

Human Prostate Gene DataBase

Name adenomatosis polyposis coli
Symbol APC
Aliases GS; DP2; DP3; FAP; FPC; DP2.5
Gene Product
  • adenomatosis polyposis coli
Category
  • Methylation in Prostate cancer
  • Mutation in Prostate cancer
UniGeneHs.75081
OMIM175100
Locus324
SummaryThe metabolic function of the APC gene is not known. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product.
Gene Ontology
Expression
EST (227 ESTs, 90 libraries)
Tissue ? Frequency ? Count ?
blood (4/27)0.001 5/40686
bone (1/13)0.004 2/26211
bone marrow (2/263)0.244 2/38555
brain (12/204)0.005 73/362011
cartilage (1/5)0.005 1/11018
cervix (1/7)0.001 1/28115
colon (4/853)0.183 4/165626
ear (1/2)0.002 2/12660
embryo (1/19)0.005 7/37976
eye (2/33)0.005 6/93836
foreskin (1/4)0.004 5/20040
germ cell (1/7)0.000 1/57383
head and neck (2/990)0.161 3/79796
heart (2/22)0.002 3/55494
intestine (1/4)0.036 1/11528
kidney (2/86)0.001 3/132968
liver (1/38)0.021 1/46472
lung (5/312)0.005 5/245386
muscle (2/21)0.007 6/71297
nervous (5/475)0.779 8/43438
oral cavity (1/18)0.002 5/44567
ovary (2/144)0.002 3/81880
pancreas (1/33)0.001 1/117255
placenta (2/342)0.538 3/157762
skin (1/31)0.001 2/100815
testis (5/171)1.000 22/117531
uncharacterized tissue (21/1773)0.131 42/713325
uterus (4/212)0.002 7/155110
SAGE (13062749 tags, 246 libraries)
Tissue ? Frequency ? Count ?
blood (1/1)0.281 4/145569
brain (18/19)0.634 203/2866610
cerebellum (1/1)0.751 6/256400
colon (8/8)0.531 88/1260636
eye (4/6)0.563 24/1490641
foreskin (2/2)1.000 2/19256
heart (1/1)0.114 1/84357
kidney (2/2)0.588 9/189727
lung (1/1)0.351 4/178286
mammary gland (15/19)0.745 145/1025313
muscle (2/2)0.223 3/161581
ovary (9/10)0.491 49/883482
pancreas (8/8)0.502 51/385838
prostate (13/13)0.502 125/938410
skin (1/7)0.376 1/12817
stomach (2/3)0.195 6/409395
uncharacterized tissue (18/22)0.738 168/2380929
vascular (3/3)0.209 15/373502
SNPrs377860 (G/T:coding-nonsyn);  rs2253987 (C/T:intron);  rs918397 (A/C:intron);  rs458492 (A/G:intron);  rs391816 (A/C:locus-region);  rs2952615 (T/C:intron);  rs1882619 (C/T:locus-region);  rs1697914 (T/C:locus-region);  rs459552 (A/T:coding-nonsyn);  rs464338 (C/G:locus-region);  rs2909958 (A/G:intron);  rs548710 (T/C:intron);  rs392907 (G/A:intron);  rs395266 (T/C:intron);  rs1804197 (A/C:mrna-utr);  rs1801155 (G/C:coding-nonsyn);  rs42427 (A/G:coding-nonsyn);  rs1966476 (A/C:intron);  rs2546106 (T/A:intron);  rs544243 (T/G:intron);  rs464002 (A/G:locus-region);  rs2545169 (G/A:intron);  rs551052 (G/A:intron);  rs2901844 (A/G:intron);  rs2652288 (T/C:coding-nonsyn);  rs2416295 (A/G:intron);  rs1816769 (C/G:intron);  rs376845 (C/A:locus-region);  rs2439589 (C/T:intron);  rs1616230 (A/G:locus-region);  rs415045 (A/T:locus-region);  rs861674 (T/A:locus-region);  rs1974786 (C/G:locus-region);  rs1807226 (C/T:intron);  rs569940 (T/C:intron);  rs2707761 (C/G:intron);  rs2229993 (C/G:coding-nonsyn);  rs2464801 (T/C:locus-region);  rs399574 (A/C:intron);  rs448475 (C/G:mrna-utr);  rs1109248 (A/T:intron);  rs458906 (G/C:intron);  rs396321 (C/T:intron);  rs414362 (C/T:locus-region);  rs419537 (C/T:locus-region);  rs1734242 (C/G:locus-region);  rs2545154 (A/G:intron);  rs469336 (G/C:locus-region);  rs1644239 (A/G:locus-region);  rs1803556 (G/T:coding-nonsyn);  rs454886 (C/T:intron);  rs1661032 (T/C:locus-region);  rs401908 (T/C:intron);  rs2431238 (A/G:intron);  rs436108 (A/C:intron);  rs2455294 (G/A:locus-region);  rs2304792 (A/G:intron);  rs464708 (G/T:intron);  rs414098 (A/G:intron);  rs511906 (T/C:intron);  rs1465910 (A/G:locus-region);  rs380589 (T/C:intron);  rs817584 (T/C:locus-region);  rs467033 (T/A:intron);  rs563556 (G/C:intron);  rs866006 (A/C:coding-nonsyn);  rs2112210 (A/G:locus-region);  rs1049291 (C/T:locus-region);  rs1822163 (C/T:locus-region);  rs460197 (A/C:intron);  rs1441375 (A/G:locus-region);  rs389657 (A/G:intron);  rs458967 (C/T:intron);  rs2019720 (A/G:locus-region);  rs397768 (G/A:mrna-utr);  rs411356 (T/C:intron);  rs517947 (A/C:intron);  rs390092 (A/C:intron);  rs1914 (A/T:intron);  rs468293 (T/G:locus-region);  rs2431505 (T/C:intron);  rs2909784 (C/G:intron);  rs1922663 (C/T:locus-region);  rs392179 (A/G:intron);  rs2251913 (A/G:intron);  rs2546116 (T/A:intron);  rs375377 (T/C:locus-region);  rs501250 (C/G:intron);  rs2545158 (A/G:intron);  rs466901 (C/T:intron);  rs1613148 (A/G:intron);  rs366913 (T/C:intron);  rs465687 (T/C:intron);  rs351771 (G/A:intron);  rs369952 (G/A:intron);  rs41115 (C/T:mrna-utr);  rs2289484 (T/G:intron);  rs465899 (T/C:coding-nonsyn);  rs3068629 (TCTG/-:intron);  rs2020383 (C/T:locus-region);  
EvidenceMethylation in Prostate cancer Mutation in Prostate cancer

© 2002, PGDB, All Rights Reserved.
Department of Urology
Universityof California, San Francisco